An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.

Background: Depression is quite common among cancer patients. It has yet to be determined which antidepressant is the most effective in cancer patients with depression.

Methods: The present study included 21 consecutive depressed oncology patients of whom 19 were followed up for 6 months.